Recipharm, a global contract development and manufacturing organisation (CDMO), has announced a new sterile cream and ointment line at its site in Odivelas, Portugal, designed for a wide range of sterile applications, including ophthalmics.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.